The many different faces of major depression: it is time for personalized medicine.

Korte, S Mechiel; Prins, Jolanda; Krajnc, Anne M; Hendriksen, Hendrikus; Oosting, Ronald S; Westphal, Koen G; Korte-Bouws, Gerdien A H; Olivier, Berend

Korte, S Mechiel; Prins, Jolanda; Krajnc, Anne M; Hendriksen, Hendrikus; Oosting, Ronald S; Westphal, Koen G; Korte-Bouws, Gerdien A H; Olivier, Berend.

Afiliação

Korte SM; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands.
Prins J; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands.
Krajnc AM; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands.
Hendriksen H; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands.
Oosting RS; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands.
Westphal KG; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands.
Korte-Bouws GA; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands.
Olivier B; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands.

Eur J Pharmacol ; 753: 88-104, 2015 Apr 15.

Article em En | MEDLINE | ID: mdl-25592320

Assuntos

Antidepressivos/uso terapêutico; Transtorno Depressivo Maior/tratamento farmacológico; Medicina de Precisão/métodos; Animais; Antidepressivos/farmacologia; Encéfalo/efeitos dos fármacos; Endofenótipos; Humanos; Inibidores da Captação de Neurotransmissores/farmacologia; Inibidores da Captação de Neurotransmissores/uso terapêutico; Recompensa

Palavras-chave

Amitifadine (DOV 21,947EB-1010) (PubChem CID: 11680542); Bupropion (PubChem CID: 444); DOV 216,303; DOV 216,303 (PubChem CID: 9795276); Depression; Dopamine; Duloxetine (PubChem CID: 60835); Escitalopram (PubChem CID: 146570); Fluoxetine (PubChem CID: 3386); Fluvoxamine (PubChem CID: 5324346); Intracranial self-stimulation; Methylphenidate; Methylphenidate (PubChem CID: 4158); Microdialysis; Milnacipran (PubChem CID: 65833); Reboxetine (PubChem CID: 65856); Selegiline (PubChem CID: 26757); Tesofensine (PubChem CID: 11370864); Venlafaxine (PubChem CID: 5656)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior / Medicina de Precisão / Antidepressivos Limite: Animals / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google